Valuation: PROT DIAG

Market Cap 196M 19.65M 17.71M 16.36M 14.79M 27.98M 1.84B 28.67M 78.16M 987M 73.74M 72.18M 3.14B P/E 2024
-2.94x
P/E 2025 -4.28x
Enterprise Value 155M 15.58M 14.04M 12.97M 11.73M 22.19M 1.46B 22.74M 61.97M 783M 58.47M 57.23M 2.49B EV / Sales 2024
2.16x
EV / Sales 2025 4.15x
Free-Float
12.26%
Yield 2024 *
-
Yield 2025 -
1 day-3.44%
1 week-9.45%
Current month-13.31%
1 month-15.56%
3 months-8.44%
6 months+17.29%
Current year-9.05%
1 week 16.28
Extreme 16.28000000
18.2
1 month 16.28
Extreme 16.28000000
19.16
Current year 12.46
Extreme 12.46
23.35
1 year 12.46
Extreme 12.46
23.35
3 years 11.7
Extreme 11.7
88.4
5 years 11.7
Extreme 11.7
169.5
10 years 11.7
Extreme 11.7
806
Manager TitleAgeSince
Chief Executive Officer 62 01/07/2020
Director of Finance/CFO 68 -
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Director/Board Member 70 01/01/2020
Director/Board Member 62 -
Director/Board Member 52 01/10/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.44%-9.45%-17.78%-52.67% 19.65M
-1.64%+3.99%+19.71%+58.13% 266B
-0.20%+3.02%+6.28%+18.98% 166B
-1.08%-3.91%-21.35%+59.38% 156B
-1.60%+0.76%-56.80%-16.25% 65.41B
-0.58%+5.53%+24.33%+64.71% 60.84B
-0.14%-2.84%-2.45%-7.80% 53.75B
-1.71%+1.00%+14.50%+61.45% 49.89B
-1.80%-3.17%+1.11%+80.61% 49.34B
-0.44%+1.99%+19.29%+84.11% 46.28B
Average -1.16%-0.90%-1.32%+35.06% 91B
Weighted average by Cap. -0.96%-0.39%+2.47%+45.18%

Financials

2024 2025
Net sales 36.33M 3.64M 3.28M 3.03M 2.74M 5.18M 341M 5.31M 14.48M 183M 13.66M 13.37M 582M 42.2M 4.23M 3.81M 3.52M 3.18M 6.02M 397M 6.17M 16.82M 212M 15.87M 15.53M 676M
Net income -26.94M -2.7M -2.43M -2.25M -2.03M -3.84M -253M -3.94M -10.74M -136M -10.13M -9.91M -431M -49.71M -4.98M -4.49M -4.15M -3.75M -7.09M -467M -7.27M -19.81M -250M -18.69M -18.3M -796M
Net Debt -15.73M -1.58M -1.42M -1.31M -1.19M -2.25M -148M -2.3M -6.27M -79.2M -5.92M -5.79M -252M -40.61M -4.07M -3.67M -3.39M -3.06M -5.79M -382M -5.94M -16.18M -204M -15.27M -14.95M -650M
Projected Income Statement - Annual - PROT DIAG
Logo PROT DIAG
Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.
Employees
22
Date Price Change Volume
11/11/26 SEK 16.28 -3.44% 26,966
10/11/26 SEK 16.86 -5.92% 27,019
09/11/26 SEK 17.92 -1.54% 6,997
06/11/26 SEK 18.20 +3.41% 5,576
05/11/26 SEK 17.60 -2.11% 17,176
  1. Stock Market
  2. Stocks
  3. PRLD Stock